1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:cSVD-derived quantitative analysis of CBF, CBV, and MTT for gray matter and white matter in half-dose (0.05-mmol/kg) and full-dose (0.1-mmol/kg) contrast groupsa
Contrast Dose cSVD-Processed DSC GM t Test (P Value) WM t Test (P Value) FD HD FD HD CBF (mL/100 g/min) 68.7 ± 23.1 38.4 ± 19.6 <.001b 19.4 ± 6.4 10.8 ± 3.9 <.001b CBV (mL/100 g) 2.4 ± 1 1.7 ± 0.8 .002b 1.3 ± 0.6 0.8 ± 0.4 <.001b MTT (sec) 4.4 ± 0.9 5.5 ± 1.8 .005b 4.1 ± 1.7 5.9 ± 2.3 .008b